Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2004, Seraph Direct is a venture capital organization based in North America that focuses on angel investing. The firm allows its members to invest in early-stage companies, providing a platform that facilitates investment tracking and management. Over the years, Seraph Direct has built a diverse portfolio of more than 140 companies, deploying over $150 million through various investment rounds.
The organization emphasizes a structured approach to investment, conducting professional due diligence and negotiating investment structures that align with the interests of its members. Membership is limited to accredited investors as defined by the SEC, ensuring a network of qualified individuals engaged in the investment process.
Seraph Direct targets early-stage companies across a wide range of industries and geographies, focusing primarily on pre-seed, seed, and seed-plus investment stages. The firm conducts thorough due diligence to assess potential investments, ensuring that members are well-informed before committing capital. Investment structures are negotiated to align with the specific needs of both the investors and the startups.
Members benefit from a platform that allows them to track their investments and stay updated on portfolio performance. This structured approach to investment not only enhances transparency but also fosters a collaborative environment among accredited investors looking to diversify their portfolios.
Seraph Direct has invested in over 140 companies, although specific names and descriptions of these portfolio companies are not disclosed in the available information. The firm’s broad investment strategy encompasses various sectors, reflecting its commitment to supporting diverse early-stage ventures.
While notable exits or current valuations are not detailed, the extensive portfolio indicates a significant engagement in the startup ecosystem, providing members with opportunities to invest in a wide array of innovative companies across North America.
Founders interested in pitching to Seraph Direct should submit their applications through the official website. A well-structured pitch deck that includes key metrics, market analysis, and a clear business model is essential. Response times may vary, so founders should be prepared for potential follow-up inquiries.
What are Seraph Direct's investment criteria?
Seraph Direct focuses on early-stage companies in the pre-seed, seed, and seed-plus stages. The firm conducts professional due diligence and emphasizes structured investment negotiations.
How can I apply or pitch to Seraph Direct?
Membership inquiries and applications can be initiated through the Seraph Direct website. Interested parties must be accredited investors as defined by the SEC.
What makes Seraph Direct different from other investors?
Seraph Direct specializes in angel investing, providing a platform for members to track their investments and ensuring a structured approach to due diligence and investment negotiations.
What is the geographic focus of Seraph Direct?
The firm primarily invests in early-stage companies located in North America, allowing for a concentrated approach to regional opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, Seraph Direct focuses on early-stage investments, which typically range from smaller amounts suitable for pre-seed and seed funding rounds.
What kind of support does Seraph Direct provide post-investment?
Seraph Direct offers a platform for members to track their investments, but specific details on operational support or mentorship are not provided in the available information.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.